Mineralys Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -6 | -13 | -15 | -16 |
EBITDA | -39,333 | -32,221 | -36,917 | -43,258 |
EBIT | -39,339 | -32,234 | -36,932 | -43,274 |
Net Income | -39,339 | -32,234 | -36,932 | -43,274 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -39,471 | -37,903 | -28,872 | -30,169 |
Cash | 112,779 | 172,921 | 217,597 | 101,788 |
Basic Shares | 82,834 | 80,545 | 70,594 | 65,451 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -59 | -43 | ||
EBITDA | -154,592 | -177,767 | -71,898 | -31,479 |
EBIT | -154,651 | -177,810 | -84,824 | -31,479 |
Net Income | -154,651 | -177,810 | -71,898 | -29,799 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -142,431 | -166,410 | -81,173 | -29,221 |
Cash | 172,921 | 114,091 | 49,304 | 87,701 |
Basic Shares | 67,656 | 48,539 | 36,188 | 5,167 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.47 |
2025-12-31 | -$0.40 |
2025-09-30 | -$0.52 |
2025-06-30 | -$0.66 |